| Message: | Estrogenic Steroids Testolactone
Product Name: Testolactone
Alias: Dehydrotestolactone
CAS: 968-93-4
EINECS: 213-534-6
MF: C19H24O3
MW: 300.3921
Assay: 97%
Grade: Pharmaceutical Grade
Appearance: White Powder
Usage: Pharmaceutical Raw Materials
Application: Antineoplastic; non-selective steroidal aromatase inhibitor that prevents the conversion from androgen to estrogen. Used in in the treatment of familial male precocious puberty. An effective anti-tumor agent.
Testolactone (brand name Teslac) is an antineoplastic agent that is a derivative of progesterone and is used to treat advanced stage breast cancer.
Testolactone is a synthetic antineoplastic agent that is structurally distinct from the androgen steroid nucleus in possessing a six-membered lactone ring in place of the usual five-membered carbocyclic D-ring. Despite some similarity to testosterone, testolactone has no in vivo androgenic effect. No other hormonal effects have been reported in clinical studies in patients receiving testolactone.
This drug is mainly used for treating various types of breast cancer in women who have been through menopause or whose ovaries no longer function.It works by blocking the production of estrogen, which helps prevent the growth of breast cancers that are activated by estrogen. It may also prevent tumor cells from being activated by other hormones.It also has been used to postpone precocious puberty because of its ability to block estrogen production.
|
my account
